Davies, B. I., Maesen, F. P. V., Jevons, S., Brouwers, J.
A group of 20 patients with acute exacerbations of chronic bronchitis was treated with the combination of 750 mg sulbactam pivoxyl (CP-47,904) with 800 mg bacampicillin orally twice daily for 10...
Fluconazole and testosterone: in vivo and in vitro studies.
Hanger, D P, Jevons, S, Shaw, J T
Fluconazole (UK-49,858), a novel bis-triazole antifungal agent, was given orally to groups of 10 male volunteers at doses of 25 and 50 mg/day for 28 days. Blood samples for testosterone estimation...
Humphrey, M J, Jevons, S, Tarbit, M H
The pharmacokinetic profile of UK-49,858 (fluconazole), a novel triazole antifungal agent which is being developed for oral and intravenous use, was determined in mice, rats, dogs, and humans....
In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic
Jevons, S., Cheeseman, H. E., Brammer, K. W.
The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli...
UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes
Andrews, R. J., Brammer, K. W., Cheeseman, H. E., Jevons, S.
UK-18,892, a new semisynthetic aminoglycoside, was active against bacteria possessing aminoglycoside-inactivating enzymes, with the exception of some known to possess AAC(6′) or AAD(4′) enzymes....
Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative
Jevons, S., Gymer, G. E., Brammer, K. W., Cox, D. A., Leeming, M. R. G.
Tioconazole (UK-20,349), a new antifungal imidazole derivative, was compared with miconazole for activity in vitro against Candida spp., Torulopsis glabrata, Cryptococcus neoformans, Aspergillus...
Fluconazole and testosterone: in vivo and in vitro studies.
Hanger, D P, Jevons, S, Shaw, J T
Fluconazole (UK-49,858), a novel bis-triazole antifungal agent, was given orally to groups of 10 male volunteers at doses of 25 and 50 mg/day for 28 days. Blood samples for testosterone estimation...
Humphrey, M J, Jevons, S, Tarbit, M H
The pharmacokinetic profile of UK-49,858 (fluconazole), a novel triazole antifungal agent which is being developed for oral and intravenous use, was determined in mice, rats, dogs, and humans....
In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic
Jevons, S., Cheeseman, H. E., Brammer, K. W.
The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli...
UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes
Andrews, R. J., Brammer, K. W., Cheeseman, H. E., Jevons, S.
UK-18,892, a new semisynthetic aminoglycoside, was active against bacteria possessing aminoglycoside-inactivating enzymes, with the exception of some known to possess AAC(6′) or AAD(4′) enzymes....
Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative
Jevons, S., Gymer, G. E., Brammer, K. W., Cox, D. A., Leeming, M. R. G.
Tioconazole (UK-20,349), a new antifungal imidazole derivative, was compared with miconazole for activity in vitro against Candida spp., Torulopsis glabrata, Cryptococcus neoformans, Aspergillus...